Product Categories
| Country: | China |
|---|---|
| Tel: | 18627753421 |
| Mobile: | +8618627756402 |
| E-mail: | 3001009495@qq.com |
| QQ: | 3001051413 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Darunavir Impurity A | C20H29N3O3S | 169280-56-2 | Details |
| Erlotinib Impurity 26 | C9H10O4 | 3943-89-3 | Details |
| Desoximetasone Impurity E | C24H33FO6 | 1524-94-3 | Details |
| Ezetimibe Impurity M | C20H21NO4 | Details |
| Erlotinib-d6 HCl | C22H18ClD6N3O4 | 1189953-78-3 | Details |
| Erlotinib Hydrochloride iMpurity 15 | Details |
| Febuxostat Impurity 26;3-cyano-4-isobutoxybenzoic acid | C14H12N2O3S | 1886961-39-2 | Details |
| Febuxostat Impurity 27;3-cyano-4-isobutoxybenzamide | Details |
| Dexamethasone EP Impurity F | C22H29FO4 | 382-67-2 | Details |
| Valsartan Methyl Ester | C18H20N2O3S | 2375033-35-3 | Details |
| Erlotinib Impurity 1 | C22H24ClN3O4 | 2204518-92-1 | Details |
| Darunavir Impurity 19 | C20H29N3O3S | 1402142-62-4 | Details |
| Febuxostat Impurity 46 | C12H13NO3 | 528607-60-5 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl | C21H22ClN3O4 | 183365-34-6 | Details |
| Desmethyl Erlotinib Carboxylate Acid | C21H19N3O5 | 1170354-84-3 | Details |
| DNV-II impurity 1 | C25H35N3O7S | 1005324-46-8 | Details |
| erythro-Hydroxy Bupropion HCl | C13H21Cl2NO | 80478-43-9 | Details |
| Febuxostat Impurity 42 | C12H14O5 | 100118-38-5 | Details |
| Febuxostat Impurity 45 | C11H10N2O | 1229019-33-3 | Details |
| Captopril Impurity 1 | C9H15NO3S | 119238-52-7 | Details |
| Erlotinib iMpurity 41 | C8H7N | 14235-81-5 | Details |
| Erlotinib Impurity 35 | C13H17N3O4 | 1839513-98-2 | Details |
| Rosuvastatin EP Impurity A | C21H28O2 | 25093-47-4 | Details |
| Erlotinib Impurity 30 | C15H22O6 | 183322-16-9 | Details |
| (R)-Amlodipine | C24H30O6 | 2884-51-7 | Details |
| Darunavir-N-Glucuronide | C33H45N3O13S | 1159613-25-8 | Details |
| Erlotinib Impurity | C21H22ClN3O4 | 183320-51-6 | Details |
| Erlotinib Impurity 45 | C21H20ClN3O3 | 183321-83-7 | Details |
| Erlotinib Impurity 1 | C22H23N3O5 | 882420-22-6 | Details |
| Pitavastatin Impurity 54 | C50H50CaN2O8 | 1258947-30-6 | Details |
| 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl) | Details |
| Erlotinib Impurity 71 | C24H25N3O5 | 2055840-54-3 | Details |
| Erlotinib Impurity 46 | C16H11N3O2 | 938185-06-9 | Details |
| Febuxostat Impurity 41;4-hydroxybenzothioamide | C19H19N3O3S | Details |
| Dexamethasone EP Impurity D | C22H28O5 | 24916-90-3 | Details |
| Darunavir Impurity 2 | C22H31N3O5S | 1526916-57-3 | Details |
| Febuxostat Impurity 50;ethyl 2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylate | C17H18N2O3S | 144060-84-4 | Details |
| Esomeprazole Impurity 25;2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole | C8H8N2O3S | 1080689-87-7 | Details |
| Desoximetasone Impurity C | Details |
| Erlotinib iMpurity 40 | C8H7N | Details |
| Erlotinib Impurity 11 | C21H19N3O5 | 882172-60-3 | Details |
| Erlotinib Impurity 66 | C13H17NO7 | 1384975-87-4 | Details |
| Erlotinib Impurity 11 | C16H23N3O4 | 950596-59-5 | Details |
| Ezetimibe Impurity Q1;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one | C27H26FNO6 | Details |
| Esomeprazole Impurity 22 | C9H12ClNO2S | Details |
| Febuxostat Impurity 30;(Z)-ethyl 2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | Details |
| Febuxostat Impurity 37 | C18H20N2O3S | 2230270-05-8 | Details |
| Erlotinib Impurity 39 | Details |
| Darunavir Impurity 7 (S,S-Isomer) | C20H29N3O3S | 192800-79-6 | Details |
| Desoximetasone Impurity 16 | C28H32FNO6 | 2265-64-7 | Details |
| Desoximetasone Impurity 17 | C29H34FNaO9S | 3936-02-5 | Details |
| Erlotinib Impurity 29 | C13H19NO6 | 574738-66-2 | Details |
| DL-Folic Acid | C19H19N7O6 | 65165-92-6 | Details |
| DNV-II impurity 2 | C25H35N3O7S | 1133153-38-4 | Details |
| Febuxostat Impurity 30 | C18H22N2O4S | 1271738-74-9 | Details |
| Febuxostat Impurity 44;ethyl 2-(3-formyl-2-hydroxyphenyl)-4-methylthiazole-5-carboxylate | C17H18N2O3S | Details |
| Febuxostat Impurity 52 | C16H16N2O4S | Details |
| Dexamethasone-17-Ketone | C20H25FO3 | 2285-53-2 | Details |
| D-Folic Acid | C19H19N7O6 | 65165-91-5 | Details |
| Febuxostat Impurity 52 | C11H14O2 | 18962-07-7 | Details |
| Desoximetasone Impurity | C36H53FN4O6S | 85679-56-7 | Details |
| Darunavir-O-Glucuronide | C33H45N3O13S | 1159613-27-0 | Details |
| Darunavir Impurity 9 | C7H10O4 | 866594-61-8 | Details |
| Cilnidipine Impurity 27 | C21H28O2 | 152-62-5 | Details |
| Febuxostat Impurity 53;isobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | C24H28N2O5S2 | 1346238-13-8 | Details |
| Febuxostat Impurity 32;2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylic acid | C12H12N2O | 1805770-41-5 | Details |
| Febuxostat Impurity 43;4-hydroxyisophthalonitrile | Details |
| Febuxostat Impurity 47;2-(2-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid | C18H21NO4S | Details |
| Erlotinib impurity 70 | C13H19NO5 | 1494468-76-6 | Details |
| D-Fudosteine | C6H13NO3S | 1023971-10-9 | Details |
| Didesmethyl Erlotinib | C20H19N3O4 | 183321-84-8 | Details |
| Darunavir-d9 | C27H37N3O7S | 1133378-37-6 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M13) | C21H21N3O4 | 183320-29-8 | Details |
| Ezetimibe Impurity Q2;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one | C27H28FNO6 | Details |
| Febuxostat Impurity 31;diethyl 2,2'-(4-hydroxy-5-(hydroxymethyl)-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) | Details |
| Febuxostat Impurity 82 | C18H21NO4S | 2230270-03-6 | Details |
| D-Darunavir | C27H37N3O7S | 1399859-60-9 | Details |
| Tacrolimus Diene | C43H67NO12 | 132172-14-6 | Details |
| Erlotinib Impurity 67 | C21H20ClN3O3 | 183321-85-9 | Details |
| Erlotinib Hydrochloride iMpurity 14 | Details |
| Febuxostat Impurity 36;2-(3-cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid | C12H12N2O | 1805770-40-4 | Details |
| Dexamethasone Sodium Phosphate EP Impurity H | C22H30FO8P-2 | 162968-22-1 | Details |
| Desoximetasone Impurity | C22H27FO6 | 473273-04-0 | Details |
| 3, 4-dihydroxybenzaldehyde | C7H6O3 | 139-85-5 | Details |
| Tacrolimus EP Impurity E | C44H71NO12 | 104987-30-6 | Details |
| Febuxostat Impurity 47 | C12H14N2O2 | 161718-85-0 | Details |
| Erlotinib Impurity 68 | C20H17Cl2N3O2 | 183321-82-6 | Details |
| Febuxostat Impurity 46 | C13H13NO3S | 118485-48-6 | Details |
| Febuxostat iMpurity 20 | Details |
| Esomeprazole Impurity 23 | C17H19N3O3S2 | Details |
| Dexamethasone Impurity G | C24H31FO5 | 1597-78-0 | Details |
| Febuxostat Impurity 106 | C18H22N2O4S | 1346238-15-0 | Details |
| Febuxostat Impurity 49;ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | Details |
| Noradrenaline Impurity 26 | C22H23N3O4 | 68304-21-3 | Details |
| Erlotinib Hydrochloride iMpurity 18 | Details |
| Ezetimibe Impurity R | C27H24FNO5 | Details |
| Febuxostat Impurity 40;4-hydroxybenzonitrile | Details |
| Esomeprazole Impurity 24 | Details |
| Desoximetasone Impurity B | Details |
| Desoximetasone Impurity | C7H8Cl2N6 | 82778-08-3 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | ||||